Bone Biologics Corporation
NASDAQ: BBLG0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Jeffrey Frelick
- Employees
- 2
- Headquarters
- Burlington, United States
- IPO year
- 2021
- Market cap
- $2.4M
- Website
- https://www.bonebiologics.com
Loading BBLG…
Loading profile data…Frequently asked questions about BBLG
What does Bone Biologics Corporation (BBLG) do?
Bone Biologics Corporation, a medical device enterprise, specializes in fostering bone regeneration for spinal fusion, leveraging its advanced recombinant human protein technology. Its flagship product, NELL-1/DBX, is a unique combination of an osteostimulative recombinant protein designed for precise, targeted control over bone regrowth. The co...
Where does BBLG trade?
Bone Biologics Corporation (BBLG) trades on the NASDAQ Capital Market.
What sector is BBLG in?
Bone Biologics Corporation (BBLG) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Bone Biologics Corporation?
Jeffrey Frelick is the chief executive officer of Bone Biologics Corporation (BBLG).
Where is Bone Biologics Corporation headquartered?
Bone Biologics Corporation is headquartered in United States.
Does BBLG pay a dividend?
Bone Biologics Corporation (BBLG) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BBLG go public?
Bone Biologics Corporation (BBLG) completed its initial public offering in 2021.